North America

The mRNA Cancer Vaccine Story Just Got Less Comfortable

Three drugs, three biological hypotheses: Kardigan is putting precision cardiology to the test

RAS Has Finally Hit Pancreatic Cancer. Now Access Has to Catch Up.

Polycythemia Vera Gets a First-in-Class Option. Patients Need More Than Blood Draws.

Cardiometabolic risk leaves a protein signature in childhood. Could it guide prevention decades earlier?

HER2 Testing Just Became the Gatekeeper in Gastroesophageal Cancer

Virtual reality may solve one of cardiac imaging’s most overlooked barriers

Obesity drugs may move beyond appetite suppression. Moonwalk just raised $70 million to target fat tissue directly

Brain Tumour Surgery Is Getting Smaller. Access Cannot Stay Elite.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
